Non-small Cell Lung Caner
2 clinical trials · Condition
◉ Watch Non-small Cell Lung Caner
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC (NCT07562581) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2026-06-01 |
| AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study (NCT07110259) | Jianxing He | 2025-07-31 |
Track Non-small Cell Lung Caner automatically
Every clearance here is in the API, with alerts when new ones post.